Guru Singh

Founder & CEO @scispotter | Host @talkisbiotech | Building the Best Tech Stack for Labs

[Guillermo Rauch @rauchg]

1 hour of TravisCore to build and accelerate to

[Guru Singh @gursatya]

Canada and India are natural partners. Canada has rich natural resources and strong research. India has a large talent pool and a fast-growing manufacturing base.

[Narendra Modi @narendramodi]

Welcomed Canada’s Foreign Minister, Ms. Anita Anand. Discussed ways to strengthen cooperation in trade, technology, energy, agriculture and people-to-people exchanges for mutual growth and prosperity.

@AnitaAnandMP

[Scispot (YC S21) @scispotter]

Hear from Scispot CEO Guru Singh(@gursatya) at Bioprocessing Summit!

Learn the 6-step playbook to transform scattered Excel files into unified, AI-ready data systems that cut release times.

📅 August 20 | 2:30 PM
📍 Momentum C - Level 5, Omni Boston Hotel

#BioprocessingSummit

[Paul Graham @paulg]

I didn't realize this till recently, but when big, bureaucratic organizations create incubators, the startups that come out of them are damaged from the start by focusing on big customers instead of the scrappy early adopters that successful startups usually sell to.

[talkisbiotech @talkisbiotech]

"Biotech is a team sport..."

Do you think teamwork helps in biotech?

Share your thoughts! 👇

#talkisbiotech

@gursatya

[talkisbiotech @talkisbiotech]

You’ll never feel ready to start a biotech startup. Start anyway.

Biotech should feel like Lego—snap parts together and build life.

On the next Talk is Biotech, hear from misfits who started before they fully knew how.

@bkevinchen @gursatya

[Scispot (YC S21) @scispotter]

Did you know?

Scispot’s alt-QMS automates quality & compliance management, reducing errors and improving efficiency.

Simplify SOP tracking, training, and audits with AI-powered tools and no-code workflows.

Stay compliant effortlessly.

Learn more: https://t.co/vyvY1Dh3sn

[talkisbiotech @talkisbiotech]

Episode 4 of talk is biotech! is coming soon!

Join @bkevinchen , Co-Founder & CEO of @HyasynthBio, as he dives into synthetic biology and yeast-based cannabinoid production.
Don’t miss it!
@gursatya

#talkisbiotech

[Guru Singh @gursatya]

Personal genomics, once dismissed as "recreational" genomics, has evolved into a reality that is now widely accepted, thanks to individuals like @annewoj23, who dedicated decades of their lives to it.

[Anne Wojcicki @annewoj23]

The 23andMe Special Committee released news today indicating their plan to take the company through the Chapter 11 process.   While I am disappointed that we have come to this conclusion and my bid was rejected, I am supportive of the company and I intend to be a bidder.   I have resigned as CEO of the company so I can be in the best position to pursue the company as an independent bidder. 

Nineteen years ago, when I co-founded 23andMe, the direct to consumer industry did not exist and most people had no idea why they would ever want to see their genome.   So much has changed.   There is now a thriving direct to consumer industry and over 15 million people are now 23andMe customers.   These customers are continuing to learn about their family relationships and how to optimize their health thanks to the incredible team of individuals at 23andMe who innovate and help customers gain insights from their genetic information.

What made so many of our innovations possible were the 85% of our customers who opted in to research.  Thanks to them they have empowered an incredible platform for discovery.  You enabled our pursuit into novel drug discovery and our 50 programs with GSK.   In addition, over 250 publications have come out because of you and we have meaningfully impacted the research world.   Thank you.

We have had many successes but I equally take accountability for the challenges we have today. There is no doubt that the challenges faced by 23andMe through an evolving business model have been real, but my belief in the company and its future is unwavering.  Consumers are rising up and asking for more control over their health and want greater knowledge about how to be healthy and why they may have health issues. We fought for consumers to have direct access to their information and for them to have choice and transparency with respect to their personal data.   As I think about the future, I will continue to tirelessly advocate for customers to have choice and transparency with respect to their personal data, regardless of platform.

Since 2006, we have built an incredible consumer brand with one of the world's largest and most diverse genetic communities. Our foundation was the trust and respect of our customers, and they were always the guiding light on how we made decisions. If I am fortunate enough to secure the company’s assets through the restructuring process, I remain committed to our long-term vision of being a global leader in genetics and establishing genetics as a fundamental part of healthcare ecosystems worldwide.

[Waterloo Region Record @WR_Record]

Med-Tech startup Scispot is using generative AI in its platform that is deployed in 100 labs across the U.S. and Canada for developing new drugs. The startup is generating enough revenue to nearly break even and expects rapid growth with the use of ChatGPT https://t.co/V3LgpBpt6p

[Satya Singh @productfella]

Hot take: One source of truth in biotech is a dangerous myth.

It's like trying to run your entire life through Excel.

Modern labs need an ecosystem of specialized tools working together.

Your data infrastructure should be a product, not a prison.

[talkisbiotech @talkisbiotech]

A Future Without Antibiotics?

A simple scratch could turn deadly as superbugs rise. The CDC and WHO warn antibiotic resistance is the next pandemic. Can we stop it in time?

🎙️ talk is biotech! – the race to fight antibiotic resistance.

@ivanliachko @PhaseGenomics @gursatya

[Phase Genomics @PhaseGenomics]

Tune into the @talkisbiotech podcast to hear Phase Genomics CEO @IvanLiachko share how Hi-C unlocks new DNA discoveries: “It’s a sequence of letters, but it makes shapes, colors—it makes a strawberry look like a strawberry.”

Thanks to pod host @gursatya: https://t.co/UObU6aZWJu

[talkisbiotech @talkisbiotech]

Is Entrepreneurship a Skill or a Mindset?

Talent alone doesn’t guarantee success. Mindset does.

@gursatya & Negin Ashouri break down why some thrive while others struggle.

Is entrepreneurship learned or a way of thinking?

🎙️ Watch Ep. 2 of talk is biotech! with Guru Singh.

[Guru Singh @gursatya]

Trump’s tariffs will push Canada to strengthen its economy and diversify its trading partners. They will encourage businesses and consumers to buy Canadian and hire locally. The short term will be tough, but this shift will make Canada more resilient…

[Guru Singh @gursatya]

Canada remains a fantastic place to launch a tech company and foster creativity, regardless of what the news reports. There is genuine startup assistance thanks to support from @NRC_CNRC @OCInnovation @ontariogenomics @UWVelocity @Communitech ...

[talkisbiotech @talkisbiotech]

Why build a biotech in Canada? 🇨🇦
R&D is way cheaper—salaries are 40% lower than the Bay Area, plus the currency advantage.
Companies operate at half the cost without sacrificing talent.

talk is biotech! Ep. 2:@gursatya breaks it all down.

[Guru Singh @gursatya]

Choose partners who free you to do what you do best.

That’s how startups scale strategically.

[Guru Singh @gursatya]

Startups work because they’re existential.

You win or you die trying.

Focus sharpens in the fire.

[Guru Singh @gursatya]

Focus on your sweet spot is important for a startup's success.

As a startup founder, delegate everything else.

It’s the only way to grow without burning out.

[Guru Singh @gursatya]

Radical candor and relentless action.

Two non-negotiables in startup survival.